ICU Medical (ICUI) Tops Q4 EPS by 26c

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.77, $0.26 better than the analyst estimate of $1.51. Revenue for the quarter came in at $320.5 million versus the consensus estimate of $295.33 million.

GUIDANCE:

ICU Medical sees Q1 2021 EPS of $6.50-$7.20, versus the consensus of $7.16.

• expects adjusted EBITDA to be in the range of $245 million to $265 million

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Anthropic delays planned IPO from October to November - WSJ
• Nucor projects Q3 2026 earnings above prior year, below estimates